Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Clin Microbiol ; 58(12)2020 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-32907994

RESUMO

Nontyphoidal Salmonella (NTS) are among the most common etiological agents of diarrheal diseases worldwide and have become the most commonly detected bacterial pathogen in children hospitalized with diarrhea in Vietnam. Aiming to better understand the epidemiology, serovar distribution, antimicrobial resistance (AMR), and clinical manifestation of NTS gastroenteritis in Vietnam, we conducted a clinical genomics investigation of NTS isolated from diarrheal children admitted to one of three tertiary hospitals in Ho Chi Minh City. Between May 2014 and April 2016, 3,166 children hospitalized with dysentery were recruited into the study; 478 (∼15%) children were found to be infected with NTS by stool culture. Molecular serotyping of the 450 generated genomes identified a diverse collection of serogroups (B, C1, C2 to C3, D1, E1, G, I, K, N, O, and Q); however, Salmonella enterica serovar Typhimurium was the most predominant serovar, accounting for 41.8% (188/450) of NTS isolates. We observed a high prevalence of AMR to first-line treatments recommended by WHO, and more than half (53.8%; 242/450) of NTS isolates were multidrug resistant (MDR; resistant to ≥3 antimicrobial classes). AMR gene detection positively correlated with phenotypic AMR testing, and resistance to empirical antimicrobials was associated with a significantly longer hospitalization (0.91 days; P = 0.04). Our work shows that genome sequencing is a powerful epidemiological tool to characterize the serovar diversity and AMR profiles in NTS. We propose a revaluation of empirical antimicrobials for dysenteric diarrhea and endorse the use of whole-genome sequencing for sustained surveillance of NTS internationally.


Assuntos
Anti-Infecciosos , Gastroenterite , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Criança , Criança Hospitalizada , Farmacorresistência Bacteriana , Farmacorresistência Bacteriana Múltipla/genética , Gastroenterite/epidemiologia , Genômica , Humanos , Testes de Sensibilidade Microbiana , Sorotipagem , Vietnã/epidemiologia
2.
J Infect Dis ; 219(2): 295-304, 2019 01 07.
Artigo em Inglês | MEDLINE | ID: mdl-30321351

RESUMO

Background: Nontyphoidal Salmonella (NTS) organisms are a major cause of gastroenteritis and bacteremia, but little is known about maternally acquired immunity and natural exposure in infant populations residing in areas where NTS disease is highly endemic. Methods: We recruited 503 pregnant mothers and their infants (following delivery) from urban areas in Vietnam and followed infants until they were 1 year old. Exposure to the dominant NTS serovars, Salmonella enterica serovars Typhimurium and Enteritidis, were assessed using lipopolysaccharide (LPS) O antigen-specific antibodies. Antibody dynamics, the role of maternally acquired antibodies, and NTS seroincidence rates were modeled using multivariate linear risk factor models and generalized additive mixed-effect models. Results: Transplacental transfer of NTS LPS-specific maternal antibodies to infants was highly efficient. Waning of transplacentally acquired NTS LPS-specific antibodies at 4 months of age left infants susceptible to Salmonella organisms, after which they began to seroconvert. High seroincidences of S. Typhimurium and S. Enteritidis LPS were observed, and infants born with higher anti-LPS titers had greater plasma bactericidal activity and longer protection from seroconversion. Conclusions: Although Vietnamese infants have extensive exposure to NTS, maternally acquired antibodies appear to play a protective role against NTS infections during early infancy. These findings suggest that prenatal immunization may be an appropriate strategy to protect vulnerable infants from NTS disease.


Assuntos
Anticorpos Antibacterianos/imunologia , Imunidade Materno-Adquirida/imunologia , Imunidade , Infecções por Salmonella/imunologia , Adulto , Anticorpos Antibacterianos/sangue , Estudos de Coortes , Feminino , Humanos , Lactente , Recém-Nascido , Lipopolissacarídeos/imunologia , Masculino , Análise Multivariada , Antígenos O , Fatores de Risco , Salmonella enteritidis , Salmonella typhimurium , Estudos Soroepidemiológicos , Sorogrupo , Vietnã
3.
J Clin Microbiol ; 54(4): 1094-100, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26865681

RESUMO

Diarrheal disease is a complex syndrome that remains a leading cause of global childhood morbidity and mortality. The diagnosis of enteric pathogens in a timely and precise manner is important for making treatment decisions and informing public health policy, but accurate diagnosis is a major challenge in industrializing countries. Multiplex molecular diagnostic techniques may represent a significant improvement over classical approaches. We evaluated the Luminex xTAG gastrointestinal pathogen panel (GPP) assay for the detection of common enteric bacterial and viral pathogens in Vietnam. Microbiological culture and real-time PCR were used as gold standards. The tests were performed on 479 stool samples collected from people admitted to the hospital for diarrheal disease throughout Vietnam. Sensitivity and specificity were calculated for the xTAG GPP for the seven principal diarrheal etiologies. The sensitivity and specificity for the xTAG GPP were >88% for Shigellaspp.,Campylobacterspp., rotavirus, norovirus genotype 1/2 (GI/GII), and adenovirus compared to those of microbiological culture and/or real-time PCR. However, the specificity was low (∼60%) for Salmonella species. Additionally, a number of important pathogens that are not identified in routine hospital procedures in this setting, such as Cryptosporidiumspp. and Clostridium difficile, were detected with the GPP. The use of the Luminex xTAG GPP for the detection of enteric pathogens in settings, like Vietnam, would dramatically improve the diagnostic accuracy and capacity of hospital laboratories, allowing for timely and appropriate therapy decisions and a wider understanding of the epidemiology of pathogens associated with severe diarrheal disease in low-resource settings.


Assuntos
Bactérias/isolamento & purificação , Diarreia/diagnóstico , Fezes/microbiologia , Fezes/virologia , Imunoensaio/métodos , Vírus/isolamento & purificação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Bactérias/classificação , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Sensibilidade e Especificidade , Vietnã , Vírus/classificação , Adulto Jovem
4.
Am J Trop Med Hyg ; 92(5): 1045-52, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25802437

RESUMO

We performed a prospective multicenter study to address the lack of data on the etiology, clinical and demographic features of hospitalized pediatric diarrhea in Ho Chi Minh City (HCMC), Vietnam. Over 2,000 (1,419 symptomatic and 609 non-diarrheal control) children were enrolled in three hospitals over a 1-year period in 2009-2010. Aiming to detect a panel of pathogens, we identified a known diarrheal pathogen in stool samples from 1,067/1,419 (75.2%) children with diarrhea and from 81/609 (13.3%) children without diarrhea. Rotavirus predominated in the symptomatic children (664/1,419; 46.8%), followed by norovirus (293/1,419; 20.6%). The bacterial pathogens Salmonella, Campylobacter, and Shigella were cumulatively isolated from 204/1,419 (14.4%) diarrheal children and exhibited extensive antimicrobial resistance, most notably to fluoroquinolones and third-generation cephalosporins. We suggest renewed efforts in generation and implementation of policies to control the sale and prescription of antimicrobials to curb bacterial resistance and advise consideration of a subsidized rotavirus vaccination policy to limit the morbidity due to diarrheal disease in Vietnam.


Assuntos
Infecções Bacterianas/epidemiologia , Infecções por Caliciviridae/epidemiologia , Diarreia/complicações , Norovirus/isolamento & purificação , Infecções por Rotavirus/epidemiologia , Anti-Infecciosos/farmacologia , Bactérias/efeitos dos fármacos , Infecções Bacterianas/complicações , Infecções Bacterianas/microbiologia , Infecções por Caliciviridae/complicações , Infecções por Caliciviridae/microbiologia , Pré-Escolar , Estudos Transversais , Demografia , Diarreia/epidemiologia , Diarreia/microbiologia , Feminino , Hospitalização , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Norovirus/efeitos dos fármacos , Estudos Prospectivos , Rotavirus/efeitos dos fármacos , Rotavirus/isolamento & purificação , Infecções por Rotavirus/complicações , Infecções por Rotavirus/microbiologia , Estações do Ano , Vietnã/epidemiologia
5.
Proc Natl Acad Sci U S A ; 110(43): 17522-7, 2013 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-24082120

RESUMO

Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei was introduced into Vietnam in the 1980s and has undergone localized clonal expansion, punctuated by genomic fixation events through periodic selective sweeps. We uncover geographical spread, spatially restricted frontier populations, and convergent evolution through local gene pool sampling. This work provides a unique, high-resolution insight into the microevolution of a pioneering human pathogen during its establishment in a new host population.


Assuntos
Disenteria Bacilar/epidemiologia , Doenças Endêmicas , Variação Genética , Shigella sonnei/genética , Antibacterianos/uso terapêutico , Criança , Pré-Escolar , Cromossomos Bacterianos/genética , Ciprofloxacina/uso terapêutico , Disenteria Bacilar/tratamento farmacológico , Disenteria Bacilar/microbiologia , Evolução Molecular , Fluoroquinolonas/uso terapêutico , Gatifloxacina , Genoma Bacteriano/genética , Genômica/métodos , Geografia , Humanos , Lactente , Dados de Sequência Molecular , Taxa de Mutação , Filogenia , Análise de Sequência de DNA , Shigella sonnei/classificação , Shigella sonnei/fisiologia , Vietnã/epidemiologia
7.
PLoS Negl Trop Dis ; 5(8): e1264, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21829747

RESUMO

BACKGROUND: The bacterial genus Shigella is the leading cause of dysentery. There have been significant increases in the proportion of Shigella isolated that demonstrate resistance to nalidixic acid. While nalidixic acid is no longer considered as a therapeutic agent for shigellosis, the fluoroquinolone ciprofloxacin is the current recommendation of the World Health Organization. Resistance to nalidixic acid is a marker of reduced susceptibility to older generation fluoroquinolones, such as ciprofloxacin. We aimed to assess the efficacy of gatifloxacin versus ciprofloxacin in the treatment of uncomplicated shigellosis in children. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a randomized, open-label, controlled trial with two parallel arms at two hospitals in southern Vietnam. The study was designed as a superiority trial and children with dysentery meeting the inclusion criteria were invited to participate. Participants received either gatifloxacin (10 mg/kg/day) in a single daily dose for 3 days or ciprofloxacin (30 mg/kg/day) in two divided doses for 3 days. The primary outcome measure was treatment failure; secondary outcome measures were time to the cessation of individual symptoms. Four hundred and ninety four patients were randomized to receive either gatifloxacin (n=249) or ciprofloxacin (n=245), of which 107 had a positive Shigella stool culture. We could not demonstrate superiority of gatifloxacin and observed similar clinical failure rate in both groups (gatifloxacin; 12.0% and ciprofloxacin; 11.0%, p=0.72). The median (inter-quartile range) time from illness onset to cessation of all symptoms was 95 (66-126) hours for gatifloxacin recipients and 93 (68-120) hours for the ciprofloxacin recipients (Hazard Ratio [95%CI]=0.98 [0.82-1.17], p=0.83). CONCLUSIONS: We conclude that in Vietnam, where nalidixic acid resistant Shigellae are highly prevalent, ciprofloxacin and gatifloxacin are similarly effective for the treatment of acute shigellosis.


Assuntos
Antibacterianos/uso terapêutico , Ciprofloxacina/uso terapêutico , Disenteria Bacilar/tratamento farmacológico , Fluoroquinolonas/uso terapêutico , Shigella/isolamento & purificação , Antibacterianos/efeitos adversos , Pré-Escolar , Disenteria Bacilar/sangue , Disenteria Bacilar/metabolismo , Fezes/microbiologia , Feminino , Fluoroquinolonas/efeitos adversos , Gatifloxacina , Hospitais , Humanos , Hiperglicemia/microbiologia , Hipoglicemia/microbiologia , Lactente , Masculino , Modelos de Riscos Proporcionais , Resultado do Tratamento , Vietnã
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...